Literature DB >> 23299080

3D structures and ligand specificities of nuclear xenobiotic receptors CAR, PXR and VDR.

Baojian Wu1, Sha Li, Dong Dong.   

Abstract

The nuclear receptors constitutive androstane receptor (CAR), pregnane X receptor (PXR) and vitamin D receptor (VDR) control a large array of genes that code for important proteins in humans including metabolic enzymes and transporters. 3D structures for the ligand-binding domain (LBD) of these receptors are abundantly available, providing valuable insights into the ligand-binding specificity as well as the activation mechanisms. The ligand-binding site of PXR is large and flexible, whereas those of CAR and VDR are compact and rigid, respectively. In general, the ligand profiles of the receptors are in agreement with the LBD structures. The crystal structures have greatly helped us to understand the promiscuity and/or specificity of CAR, PXR and VDR.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299080     DOI: 10.1016/j.drudis.2013.01.001

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  13 in total

1.  Widespread epigenetic changes to the enhancer landscape of mouse liver induced by a specific xenobiotic agonist ligand of the nuclear receptor CAR.

Authors:  Andy Rampersaud; Nicholas J Lodato; Aram Shin; David J Waxman
Journal:  Toxicol Sci       Date:  2019-06-24       Impact factor: 4.849

Review 2.  Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism.

Authors:  Tomas Smutny; Lucie Hyrsova; Albert Braeuning; Magnus Ingelman-Sundberg; Petr Pavek
Journal:  Arch Toxicol       Date:  2020-11-09       Impact factor: 5.153

3.  And Now for Something Completely Different: Diversity in Ligand-Dependent Activation of Ah Receptor Responses.

Authors:  Michael S Denison; Samantha C Faber
Journal:  Curr Opin Toxicol       Date:  2017-02

Review 4.  Targeting xenobiotic receptors PXR and CAR in human diseases.

Authors:  Monimoy Banerjee; Delira Robbins; Taosheng Chen
Journal:  Drug Discov Today       Date:  2014-11-20       Impact factor: 7.851

5.  Overcoming the Pregnane X Receptor Liability: Rational Design to Eliminate PXR-Mediated CYP Induction.

Authors:  Joshi M Ramanjulu; Shawn P Williams; Ami S Lakdawala; Michael P DeMartino; Yunfeng Lan; Robert W Marquis
Journal:  ACS Med Chem Lett       Date:  2021-08-10       Impact factor: 4.632

6.  Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibitors as Selective Modulators of Pregnane X Receptor from TüKIC Library.

Authors:  Enni-Kaisa Mustonen; Tatu Pantsar; Azam Rashidian; Juliander Reiner; Matthias Schwab; Stefan Laufer; Oliver Burk
Journal:  Cells       Date:  2022-04-12       Impact factor: 7.666

7.  Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.

Authors:  Magdalena Milczarek; Beata Filip-Psurska; Wiesław Swiętnicki; Andrzej Kutner; Joanna Wietrzyk
Journal:  Oncol Rep       Date:  2014-06-11       Impact factor: 3.906

Review 8.  Marine invertebrate xenobiotic-activated nuclear receptors: their application as sensor elements in high-throughput bioassays for marine bioactive compounds.

Authors:  Ingrid Richter; Andrew E Fidler
Journal:  Mar Drugs       Date:  2014-11-24       Impact factor: 5.118

9.  CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.

Authors:  Elisa M Noll; Christian Eisen; Albrecht Stenzinger; Elisa Espinet; Alexander Muckenhuber; Corinna Klein; Vanessa Vogel; Bernd Klaus; Wiebke Nadler; Christoph Rösli; Christian Lutz; Michael Kulke; Jan Engelhardt; Franziska M Zickgraf; Octavio Espinosa; Matthias Schlesner; Xiaoqi Jiang; Annette Kopp-Schneider; Peter Neuhaus; Marcus Bahra; Bruno V Sinn; Roland Eils; Nathalia A Giese; Thilo Hackert; Oliver Strobel; Jens Werner; Markus W Büchler; Wilko Weichert; Andreas Trumpp; Martin R Sprick
Journal:  Nat Med       Date:  2016-02-08       Impact factor: 53.440

10.  CINPA1 is an inhibitor of constitutive androstane receptor that does not activate pregnane X receptor.

Authors:  Milu T Cherian; Wenwei Lin; Jing Wu; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2015-03-11       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.